Bero comments on corporate funding and academic research

Lisa Bero, PhD, UCSF School of Pharmacy faculty member, looks at the potential benefits, risks, and ethical issues of different corporate/academic funding models. She also calls for a research agenda aimed at clarifying the effects of these relationships on research integrity, faculty attitudes, technology transfer, and research productivity. Her comments appear in the June 4, 2008 online version of the Journal of Epidemiology under the title "'Experimental institutional' models for corporate funding of academic research: Unknown effects on the research enterprise."

Full story

"Experimental" Institutional Models for Corporate Funding of Academic Research: Unknown Effects on the Research Enterprise


School of Pharmacy, Department of Clinical Pharmacy, PharmD Degree Program

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.